+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Invasive aspergillosis in surgical intensive care patients

Annales Francaises D'anesthesie et de Reanimation 12(4): 379-384

Invasive aspergillosis in surgical intensive care patients

Aspergillosis is a rare event in intensive care patients. Three cases of invasive aspergillosis due to Aspergillus fumigatus were diagnosed in a surgical critical care unit. Risk factors for aspergillosis were found in two liver transplanted patients. One of them had a primitive cutaneous aspergillosis, and the other, treatment difficulties due to the unavailability of an injectable preparation of itraconazole, a new triazole antifungal agent efficient against Aspergillus species. The third case occurred in a patient who had had surgery for gastric carcinoma with liver metastasis. The mycological examination of the air and workbench in the patients' rooms disclosed between 2 and 13 CFU cntdot mm-3 of different Aspergillus species. Plasma itraconazole concentrations were measured in one patient only. They were below the therapeutic range, probably because of intestinal disturbances. The oral administration of itraconazole capsules through gastro-intestinal feeding tubes results in a poor availability of the drug. Such a technique of administration should therefore be undertaken with larger doses than those commonly recommended. Moreover, itraconazole plasma concentrations should be monitored. The association with amphotericin B is recommended until normal intestinal absorption has been obtained.

Accession: 002416595

PMID: 8273926

DOI: 10.1016/S0750-7658(05)80105-4

Related references

Kujath, P.; Klempien, I.; Muhl, E.; Kämmerer, R., 2001: Invasive aspergillosis on a surgical intensive care unit. From 1-1-1995 until 1-3-2000 4777 patients were treated in a surgical intensive care unit. 12 patients (10 male/2 female, mean age 58 years) suffered from invasive aspergillosis. One patient had a purulent descending mediastinitis with evidence of...

Kujath, P.; Klempien, I.; Muhl, E.; Kammerer, R., 2000: Invasive aspergillosis in a surgical intensive care unit. Between 1 January 1995 and 1 March 2000, a total of 4777 patients were treated in a surgical intensive care unit [Germany]. 12 patients (10 males and 2 females, mean age 58 years) suffered from invasive aspergillosis. One patient had a purulent de...

Xu, N.; Li, S.; Feng, R.; Wang, D., 2016: The clinical monitoring of invasive aspergillosis in surgical intensive care unit during 10 years. To investigate the invasive aspergillosis (IA) status in a surgical intensive care unit (SICU). The clinical data including general state, operation, pathogenic microorganisms, infection position, clinical situation, treatment and prognosis of pat...

Hedayati, M.T.; Khodavaisy, S.; Alialy, M.; Omran, S.Mahdavi.; Habibi, M.R., 2014: Invasive aspergillosis in intensive care unit patients in Iran. We assessed the intensive care unit (ICU) patients for Invasive aspergillosis (IA) with culture and non-culture based diagnostic methods from Iran. Thirty-six ICU patients with underlying predisposing conditions for IA were enrolled in the study....

Blot, S.; Piette, A.; Vandijck, D.; Lizy, C.; Vandewoude, K.; Vogelaers, D., 2010: The economic impact of invasive aspergillosis in intensive care unit patients. International Journal of Infectious Diseases 14(6): E536-E537

Störzinger, D.; Lichtenstern, C.; Swoboda, S.; Weigand, M.A.; Hoppe-Tichy, T., 2008: Posaconazole in intensive care patients I: invasive fungal infections in surgical intensive care and case presentation. Critically ill patients after extended surgical procedures are at high risk for postoperative infections. Fungal infections play a substantial role for immunocompromised patients, e.g. after solid organ transplantation or under chronic corticoid t...

Glöckner, A.; Karthaus, M., 2011: Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients. Sepsis is a leading cause of death in the intensive care unit (ICU), with Candida spp. in the forefront among the important pathogens. As recent studies have shown, survival outcome is strongly influenced by adequate antifungal therapy at an early...

Bulpa, P.; Dive, A.; Delos, M.; Garrino, M.; Evrard, P.; Michaux, I.; Gonzalez, M.; Malhomme, B.; Installe, E., 1998: Outcome of intensive care patients requiring mechanical ventilation during invasive pulmonary aspergillosis. European Respiratory Journal 12(SUPPL 28): 120S, Sept

Aliyali, M.; Hedayati, M.T.; Habibi, M.R.; Khodavaisy, S., 2014: Clinical risk factors and bronchoscopic features of invasive aspergillosis in intensive care unit patients. Invasive aspergillosis (IA) is an important cause of morbidity and mortality in immunocompromised patients. During recent years, a rising incidence of IA in Intensive Care Unit (ICU) patients has been reported. The patterns of IA related infection...

Rocchi, S.; Reboux, G.; Larosa, F.; Scherer, E.; Daguindeau, E.; Berceanu, A.; Deconinck, E.; Millon, L.; Bellanger, A-P., 2016: Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home. Contrary to hospital exposure, little is known about the indoor fungal exposure of hematology patients at home. The aim of our study was to investigate the mold exposure of hematology patients both at home and at hospital to assess their invasive...